Prof. Lei Liu 刘磊
Chief Physician, Professor
Department of Head and Neck Oncology, West China Hospital, Sichuan University, Chengdu
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and comprehensive treatment of malignant tumors, focusing on nasopharyngeal, oral, and oropharyngeal cancers, gliomas, and breast cancer using radiotherapy, chemotherapy, and immunotherapy.
Dr. Liu is a Professor, Chief Physician, and Doctoral Supervisor at West China Hospital, serving as Director of the Head and Neck Oncology Department. Dr. Liu contributed to developing national guidelines for head and neck oncology, nasopharyngeal cancer radiotherapy, and breast cancer radiotherapy.
Professional roles
- Member, Head and Neck Oncology Committee, Chinese Society of Clinical Oncology (CSCO)
- Member, Nasopharyngeal Cancer Group, Radiotherapy Branch, Chinese Medical Doctor Association
- Member, Central Nervous System Tumor Group, Radiotherapy Branch, Chinese Medical Doctor Association
- Chair, Nasopharyngeal Cancer Committee, Sichuan Medical Promotion Association
Name order: in Chinese the family name comes first (Liu Lei). Papers usually list the name as Lei Liu or Liu L.
Selected publications
351 papers on PubMed matched by name and affiliation; 92 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMJ Open, 2026 (first author): Comparison of underdilated versus standard transjugular intrahepatic portosystemic shunt in preventing rebleeding from oesophagogastric varices in patients with cirrhosis in Chinese tertiary hospitals: protocol for a multicentre randomised controlled trial (UVR-TIPS trial). PubMed 42556834
- Chin J Traumatol, 2026 (senior author): Which maxillofacial fractures warrant the use of intraoperative CT? A systematic review and meta-analysis. PubMed 42562722
- Front Immunol, 2026 (senior author): A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer. PubMed 42495649
- Hua Xi Kou Qiang Yi Xue Za Zhi, 2026 (senior author): [Facial scarless surgical approach for mandibular condyle fracture]. PubMed 41919536
- Biomolecules, 2026 (senior author): Extracellular Vesicles Derived from Human CD24(+) Dental Papilla Stem Cells Promote Vascularized Dental Pulp Regeneration. PubMed 41897326
- Transl Cancer Res, 2026 (senior author): VDAC1 and VDAC2 as prognostic biomarkers and therapeutic targets in hepatocellular carcinoma. PubMed 41674969
- Front Oncol, 2025 (senior author): Epithelial-myoepithelial carcinoma of the nasopharynx: cases report and literature review. PubMed 41626170
- Redox Biol, 2025 (first author): Loss of NLN suppresses lung cancer progression by inducing ferroptosis through downregulating m(6)A methylation of GPX4. PubMed 41242017
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion